Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 22, 2016
35 pages — Published Sep 22, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sage Therapeutics, Inc. (Sage) is a pharmaceutical company that develops and commercializes therapeutics and medicines for central nervous system disorders. The companys pipeline products include SAGE-547, SAGE-689 and SAGE-217. Its SAGE-547 is currently being evaluated in a phase one or two clinical trial for super refractory status epilepticus. Sages SAGE-689 is currently in preclinical development for neuroanesthesia and status epilepticus. The companys SAGE-217 is a neuroactive steroid that acts as a positive allosteric modulator of synaptic. It is also exploring other potential products in various CNS disorders based on modulation of both the GABAA and NMDA receptors.

Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped

  
Source:
Document ID
GDPH357890D
Country
Industry
Ticker
SAGE=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sage Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sage Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sage Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sage Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sage Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Sage Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details1121
  Venture Financing111
    Sage Therapeutics Raises US$38 Million In Series C Venture Financing112
    Sage Therapeutics Raises US$10 Million In Venture Financing131
    Sage Therapeutics Raises US$20 Million In Series B Venture Financing142
    Sage Therapeutics Raises US$2.8 Million In Expanded Series A Financing Round161
    Sage Therapeutics Secures US$35 Million In Series A Financing171
  Licensing Agreements181
    Sage Therapeutics Enters into Licensing Agreement with Ligand Pharma181
    Sage Therapeutics Enters into Licensing Agreement with University of California191
    Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules201
    Sage Therapeutics Amends Licensing Agreement with Regents of the University of California and University of California, Davis211
    Ligand Pharma Enters Into Licensing Agreement With Sage Therapeutics222
  Equity Offering241
    Sage Therapeutics Prices Public Offering of Shares for USD175 Million242
    Sage Therapeutics Prices Public Offering of Shares for USD150 Million262
    Sage Therapeutics Raises USD138 Million in Public Offering of Shares282
    Sage Therapeutics Raises USD103.5 Million in IPO302
Sage Therapeutics, Inc. - Key Competitors321
Key Employees331
Locations And Subsidiaries341
  Head Office341
Appendix351
  Methodology351
  About GlobalData351
  Contact Us351
  Disclaimer351

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sage-Therapeutics-Inc-SAGE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-20702>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sage Therapeutics, Inc. (SAGE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sage-Therapeutics-Inc-SAGE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-20702>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research